These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 23986604

  • 1. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
    Jha HC, Lu J, Saha A, Cai Q, Banerjee S, Prasad MA, Robertson ES.
    J Virol; 2013 Nov; 87(22):12121-38. PubMed ID: 23986604
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
    Cai Q, Guo Y, Xiao B, Banerjee S, Saha A, Lu J, Glisovic T, Robertson ES.
    PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
    [Abstract] [Full Text] [Related]

  • 3. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6.
    Sun K, Bose D, Singh RK, Pei Y, Robertson ES.
    J Virol; 2024 Jul 23; 98(7):e0054824. PubMed ID: 38864622
    [Abstract] [Full Text] [Related]

  • 4. EBNA3C regulates p53 through induction of Aurora kinase B.
    Jha HC, Yang K, El-Naccache DW, Sun Z, Robertson ES.
    Oncotarget; 2015 Mar 20; 6(8):5788-803. PubMed ID: 25691063
    [Abstract] [Full Text] [Related]

  • 5. EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.
    Banerjee S, Lu J, Cai Q, Sun Z, Jha HC, Robertson ES.
    PLoS Pathog; 2014 Aug 20; 10(8):e1004304. PubMed ID: 25121590
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
    Skalska L, White RE, Franz M, Ruhmann M, Allday MJ.
    PLoS Pathog; 2010 Jun 10; 6(6):e1000951. PubMed ID: 20548956
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
    Zhang S, Pei Y, Lang F, Sun K, Singh RK, Lamplugh ZL, Saha A, Robertson ES.
    PLoS Pathog; 2019 Jan 10; 15(1):e1007514. PubMed ID: 30615685
    [Abstract] [Full Text] [Related]

  • 9. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
    Jha HC, Shukla SK, Lu J, Aj MP, Banerjee S, Robertson ES.
    Oncotarget; 2015 Oct 06; 6(30):30115-29. PubMed ID: 26336822
    [Abstract] [Full Text] [Related]

  • 10. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
    Shukla SK, Jha HC, El-Naccache DW, Robertson ES.
    Oncotarget; 2016 Apr 05; 7(14):18116-34. PubMed ID: 26908453
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
    Maruo S, Wu Y, Ishikawa S, Kanda T, Iwakiri D, Takada K.
    Proc Natl Acad Sci U S A; 2006 Dec 19; 103(51):19500-5. PubMed ID: 17159137
    [Abstract] [Full Text] [Related]

  • 12. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
    Banerjee S, Lu J, Cai Q, Saha A, Jha HC, Dzeng RK, Robertson ES.
    PLoS Pathog; 2013 Dec 19; 9(5):e1003314. PubMed ID: 23658517
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
    Skalska L, White RE, Parker GA, Turro E, Sinclair AJ, Paschos K, Allday MJ.
    PLoS Pathog; 2013 Feb 19; 9(2):e1003187. PubMed ID: 23436997
    [Abstract] [Full Text] [Related]

  • 17. EBV persistence without its EBNA3A and 3C oncogenes in vivo.
    Murer A, McHugh D, Caduff N, Kalchschmidt J, Barros M, Zbinden A, Capaul R, Niedobitek G, Allday M, Chijioke O, Münz C.
    PLoS Pathog; 2018 Apr 19; 14(4):e1007039. PubMed ID: 29709016
    [Abstract] [Full Text] [Related]

  • 18. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Bristol JA, Ma S, Ranheim EA, Gumperz J, Johannsen EC, Kenney SC.
    PLoS Pathog; 2018 Aug 19; 14(8):e1007221. PubMed ID: 30125329
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of COBLL1 and the ADAM28-ADAMDEC1 Locus via Interaction with the Histone Lysine Demethylase KDM2B.
    Gillman ACT, Parker G, Allday MJ, Bazot Q.
    J Virol; 2018 Nov 01; 92(21):. PubMed ID: 30135119
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.
    Jha HC, A J MP, Saha A, Banerjee S, Lu J, Robertson ES.
    J Virol; 2014 Apr 01; 88(7):3776-88. PubMed ID: 24429368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.